Nitroxoline CAS 4008-48-4
  • Nitroxoline CAS 4008-48-4 Nitroxoline CAS 4008-48-4

Nitroxoline CAS 4008-48-4

Nitroxoline CAS 4008-48-4 muaj nuj nqi
Txais tos muas Nitroxoline CAS 4008-48-4 los ntawm peb. 5-nitro-8-hydroxyquinoline yog ib qho tshuaj tua kab mob rau kev kho cov kab mob urinary. Nws kuj yog ib qho zoo thiab thim rov qab cathepsin B inhibitor. Nws tau raug pov thawj tias muaj kev ua haujlwm tiv thaiv kab mob.Siv raws li kws tshuaj intermediates, fungicides, thiab lwm yam.

Xa lus nug

Product Description

Ntxiv rau cov npe khoom hauv qab no, koj tuaj yeem kho koj tus kheej tshwj xeeb Nitroxoline CAS 4008-48-4 raws li koj qhov kev xav tau tshwj xeeb. Shandong Ntseeg


Nitroxoline CAS 4008-48-4

Khoom npe

Nitroxoline

Formula

C25H15 Nr

Molecular Luj

190.16

CAS Nr.

4008-48-4

Ntau

500 KG


Cov khoom

Specification

Cov txiaj ntsig

Qhov tshwm sim

hmoov dawb

Ua raws

Assay

â € 98.0%

99.2%

Melting point

TEEB MEEM

Qhov tshwm sim ua raws li tus qauv


Nitroxoline CAS 4008-48-4


Melting point 181-183 ° C (lit.)
Kub taw tes 325.64 ° C (roughestimate)
Qhov ceev 1.3907 (roughestimate)
Refractive index 1.5570 (kwv yees)
Khaws rau hauv qhov chaw tsaus, chav sov
Solubility: heev me ntsis soluble
Acidity coefficient (PKA) 2.55 ± 0.10 (kwv yees)
Merck 14,6655


Nitroxoline CAS 4008-48-4

5-nitro-8-hydroxyquinoline yog ib qho tshuaj tua kab mob rau kev kho cov kab mob urinary. Nws kuj yog ib qho zoo thiab thim rov qab cathepsin B inhibitor. Nws tau raug pov thawj tias muaj kev tiv thaiv kab mob cancer.
Siv ua tshuaj intermediates, fungicides, thiab lwm yam



Hot Tags: Nitroxoline CAS 4008-48-4, manufacturers, neeg muag khoom, lag luam wholesale, Hoobkas, hauv Tshuag, ua nyob rau hauv Suav teb, Suav teb, pheej yig, luv nqi, zoo, API, kev tshawb fawb thiab kev loj hlob, kev cai Synthesis

Yam Qeb

Xa lus nug

Thov koj xav tias dawb muab koj qhov kev nug hauv daim ntawv hauv qab no. Peb yuav teb koj hauv 24 teev.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept